This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers | MicrobiomeTrials
← Back to trials NCT06487403
HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-04-17Est. Completion: 2028-08-01
Enrollment target: 40 participantsLocations Princess Margaret Cancer Centre, Toronto, Ontario, Canada Other microbiome trials you might be interested in Oesophageal Squamous Cell Carcinoma Oesophageal Adenocarcinoma Gastric Adenocarcinoma Pancreatic Ductal Adenocarcinoma (PDAC) Cholangiocarcinoma Hepatocellular Carcinoma (HCC) Colorectal Adenocarcinoma
The investigators of this study are developing a simple breath test to help detect gastrointestinal (gut) cancers earlie…
Maidstone, United Kingdom Est. completion Feb 2, 2028
Advanced Solid Tumors HNSCC SCLC
NSCLC
TNBC - Triple-Negative Breast Cancer
CRC
The goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will al…
New Haven, United States Est. completion Dec 2028